As of close of business last night, Candel Therapeutics Inc’s stock clocked out at $5.09, down -20.84% from its previous closing price of $6.43. In other words, the price has decreased by -$1.34 from its previous closing price. On the day, 3716273 shares were traded. CADL stock price reached its highest trading level at $6.52 during the session, while it also had its lowest trading level at $4.88.
Ratios:
To gain a deeper understanding of CADL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.59 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 1.79 whereas as Long-Term Debt/Eq ratio is at 1.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 02, 2022, initiated with a Buy rating and assigned the stock a target price of $11.
On November 19, 2021, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $18.
On August 23, 2021, UBS started tracking the stock assigning a Buy rating and target price of $9.UBS initiated its Buy rating on August 23, 2021, with a $9 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 186.65M and an Enterprise Value of 174.00M. Its current Enterprise Value per Revenue stands at 821.98 whereas that against EBITDA is -5.06.
Stock Price History:
Over the past 52 weeks, CADL has reached a high of $11.40, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 1.85, while the 200-Day Moving Average is calculated to be 1.29.
Shares Statistics:
It appears that CADL traded 4.01M shares on average per day over the past three months and 24.38M shares per day over the past ten days. A total of 29.21M shares are outstanding, with a floating share count of 15.66M. Insiders hold about 46.65% of the company’s shares, while institutions hold 5.76% stake in the company. Shares short for CADL as of Mar 15, 2024 were 147.27k with a Short Ratio of 0.04, compared to 281.16k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.51% and a Short% of Float of 0.76%.
Earnings Estimates
As of right now, 0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.3. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.91 and -$0.91 for the fiscal current year, implying an average EPS of -$0.91. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
